The company has significantly advanced its progress of the new solution for ATTR-CM, leveraging the compound. Preliminary patient information reveals significant outcomes for individuals suffering with a severe illness. https://attruby359215.theobloggers.com/48775437/bridgebio-progresses-cardiac-amyloidosis-therapy-using-the-therapy